![Randolph M. Johnson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Randolph M. Johnson
Corporate Officer/Principal presso American Society for Pharmacology & Experimental Therapeutic
Posizioni attive di Randolph M. Johnson
Società | Posizione | Inizio | Fine |
---|---|---|---|
American Society for Pharmacology & Experimental Therapeutic | Corporate Officer/Principal | - | - |
Society For Neuroscience
![]() Society For Neuroscience Miscellaneous Commercial ServicesCommercial Services The Society for Neuroscience is an organization with over 36,000 members in more than 95 countries. The non-profit company is based in Washington. The organization also engages in science advocacy and public policy, including an annual Capitol Hill Day, and has various public outreach efforts, such as the interactive collection of public-facing resources on BrainFacts.org. It was founded in 1969 and offers year-round programming, including the publication of two scientific journals, professional development resources, and career training through Neuronline. | Corporate Officer/Principal | - | - |
The Endocrine Society | Corporate Officer/Principal | - | - |
Storia della carriera di Randolph M. Johnson
Precedenti posizioni note di Randolph M. Johnson
Società | Posizione | Inizio | Fine |
---|---|---|---|
ATHERONOVA INC. | Direttore operativo | 11/04/2014 | - |
ENDONOVO THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/12/2014 | - |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
University of Virginia | Corporate Officer/Principal | - | - |
Syntex Research Centre
![]() Syntex Research Centre Pharmaceuticals: OtherHealth Technology Syntex Research Centre is a British company that provides pharmaceutical products. Syntex Research Centre was acquired by Quintiles Scotland Ltd on February 01, 1995 for $20.68 million. | Direttore Tecnico/Scientifico/R&S | - | - |
DURECT CORPORATION | Corporate Officer/Principal | - | - |
░░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
Formazione di Randolph M. Johnson
University of South Carolina | Doctorate Degree |
The California State University | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 14 |
Regno Unito | 2 |
Posizioni
Corporate Officer/Principal | 6 |
Chief Tech/Sci/R&D Officer | 5 |
Doctorate Degree | 1 |
Settori
Health Technology | 8 |
Consumer Services | 4 |
Electronic Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
DURECT CORPORATION | Health Technology |
ENDONOVO THERAPEUTICS, INC. | Health Technology |
Aziende private | 9 |
---|---|
Cellgate, Inc.
![]() Cellgate, Inc. Pharmaceuticals: MajorHealth Technology Progen Pharmaceuticals, Inc. develops biopharmaceuticals products. It is engaged in developing improved drug delivery based on their transporter molecules. The company is headquartered in Redwood City, CA. | Health Technology |
KAI Pharmaceuticals, Inc.
![]() KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA. | Health Technology |
CellGate Technologies LLC
![]() CellGate Technologies LLC Computer PeripheralsElectronic Technology Part of StarVox Communications, Inc., CellGate Technologies LLC is a company that manufactures integrated wireless IP modem adapters and provides wireless services. The company is based in Boca Raton, FL. The company was founded by Edgar G. Engleman. CellGate Technologies was acquired by U.S. Wireless Data, Inc. on November 17, 2000 for $2.23 million. | Electronic Technology |
Syntex Research Centre
![]() Syntex Research Centre Pharmaceuticals: OtherHealth Technology Syntex Research Centre is a British company that provides pharmaceutical products. Syntex Research Centre was acquired by Quintiles Scotland Ltd on February 01, 1995 for $20.68 million. | Health Technology |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
American Society for Pharmacology & Experimental Therapeutic | |
Society For Neuroscience
![]() Society For Neuroscience Miscellaneous Commercial ServicesCommercial Services The Society for Neuroscience is an organization with over 36,000 members in more than 95 countries. The non-profit company is based in Washington. The organization also engages in science advocacy and public policy, including an annual Capitol Hill Day, and has various public outreach efforts, such as the interactive collection of public-facing resources on BrainFacts.org. It was founded in 1969 and offers year-round programming, including the publication of two scientific journals, professional development resources, and career training through Neuronline. | Commercial Services |
The Endocrine Society | |
AtheroNova, Inc.
![]() AtheroNova, Inc. Pharmaceuticals: MajorHealth Technology AtheroNova, Inc. operates as biotechnology company. The company engages in the research and development, marketing, and sale of pharmaceutical preparations and pharmaceutical intellectual property. It develops intellectual property that uses certain pharmacological compounds for the treatment of atherosclerosis, which is the primary cause of various cardiovascular diseases. The company was founded by Giorgio Zadini and Filiberto Zadini in 1997 and is headquartered in Irvine, CA. | Health Technology |
- Borsa valori
- Insiders
- Randolph M. Johnson
- Esperienza